AzTrials
AzTrials

AnesthesiaSPECTRALADUPEDNCT07460414

EEG Signal Correlates During Anesthesia and Sedation in Adults and Children

An observational study of Anesthesia and Sedation, run by Assistance Publique - Hôpitaux de Paris at 2 sites in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This prospective, multicenter, non-interventional observational study investigates the correlates between electroencephalographic (EEG) signals and pharmacological/clinical parameters during general anesthesia and procedural sedation. Read more about this study

Who is it for?
Ages 1 year and older
Conditions the study is for
Anesthesia, Sedation, Consciousness Monitors
How many people
330 participants
Where
2 sitesFrance
Study dates
15 Mar 2026to 15 May 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: For adults: Patients over 70 years of age who need to benefit from general anesthesia for surgery (Bichat-Claude Bernard or Louis Mourier). Adult patients (> 18 years old) who should benefit from procedural sedation for digestive endoscopies (Louis Mourier). For children: Children over 1 year of age (and weighing > 10 kg) who need to benefit from general anesthesia for dental or ENT surgery at the Louis Mourier Hospital (including children with autism spectrum disorder)

Who may be able to join

  • For adult patients:
  • Age ≥18 years (Cohort 2: >70 years; Cohort 3: ≥18 years)
  • Scheduled for general anesthesia (Cohort 2) or procedural sedation (Cohort 3)
  • Pre-anesthetic consultation completed
  • Informed of the study and non-opposition obtained
  • For pediatric patients (Cohort 1):
Show all 11Show fewer
  • Age 1-17 years
  • Scheduled for general anesthesia for surgical procedure
  • For ASD subgroup: Confirmed DSM-5 diagnosis of autism spectrum disorder
  • Parental authority holder informed and non-opposition obtained
  • Child informed (if age-appropriate) and non-opposition obtained

Who cannot join

  • For adult patients:
  • Documented cognitive impairment in medical record
  • Patient refusal to participate
  • Patient deprived of liberty or under legal protection
  • Pregnant or breastfeeding women
  • For pediatric patients:
  • Parental refusal of child's participation
  • Child refusal (if age-appropriate to understand)

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Dan Longrois, MD, PHD contact

01 47 60 61 35

dan.longrois@aphp.fr

David Holcman, MD, PHD contact

01 44 32 36 61

holcman.david@gmail.com

France2 sites
  • Hôpital Louis Mourier

    Colombes, 92700

    Dan Longrois, MD, PHD, 01 47 60 61 35, dan.longrois@aphp.fr

    David Holcman, MD, PHD, 01 44 32 36 61, holcman.david@gmail.com

  • Hôpital Bichat-Claude Bernard

    Paris, Ap-hp DRCI, 75010

    Dan Longrois, MD, PHD, 01 47 60 61 35, dan.longrois@aphp.fr

    David Holcman, MD, PHD, 01 44 32 36 61, holcman.david@gmail.com

Other trials in France

About this study

Official title: Study of Pharmacological and Clinical Correlates of the Electroencephalographic Signal During Induction, Maintenance and Emergence Phases of General Anesthesia or Procedural Sedation in Adults and General Anesthesia in Children

This prospective, multicenter, non-interventional observational study investigates the correlates between electroencephalographic (EEG) signals and pharmacological/clinical parameters during general anesthesia and procedural sedation. The study will enroll 330 participants across three distinct populations at two AP-HP sites (Bichat-Claude Bernard Hospital and Louis Mourier Hospital):

  1. Pediatric cohort (n=110): Children aged 1-17 years undergoing general anesthesia, including 55 with autism spectrum disorder (ASD) and 55 without ASD.
  2. Elderly adult cohort (n=110): Patients over 70 years undergoing scheduled surgery under general anesthesia.
  3. Procedural sedation cohort (n=110): Adults ≥18 years undergoing procedural sedation for digestive endoscopy.
Read more

EEG data will be collected using BIS and SedLine monitors during routine anesthetic care with no modifications to standard practice. The primary objective is to identify EEG signal features correlating with clinical and pharmacological parameters during induction, maintenance, and emergence phases.

Secondary objectives include developing predictive models for anesthetic depth, analyzing age-related differences, comparing effects of different anesthetic agents, and investigating specific EEG patterns in children with ASD. This study will enhance understanding of brain responses to anesthesia across different age groups and clinical contexts, potentially improving anesthetic monitoring algorithms and management strategies.

Read the detailed description

BACKGROUND AND RATIONALE:

Monitoring depth of anesthesia using electroencephalography (EEG) has become standard clinical practice, particularly through processed indices like the Bispectral Index (BIS). However, the underlying neurophysiological mechanisms and relationships between raw EEG signals and clinical/pharmacological parameters remain incompletely understood. Current monitoring systems provide processed indices but limited insight into raw multi-channel EEG signal characteristics. Systematic analysis of EEG data across different patient populations, age groups, and anesthetic contexts is needed to advance our understanding of brain responses to anesthesia and improve monitoring strategies.

STUDY DESIGN:

This is a prospective, multicenter, non-interventional, observational cohort study conducted at two sites of the Assistance Publique - Hôpitaux de Paris (AP-HP): Bichat-Claude Bernard Hospital and Louis Mourier Hospital. The study involves no modifications to routine anesthetic care - only collection and analysis of EEG data during standard clinical practice.

STUDY POPULATIONS:

The study will enroll 330 participants across three distinct cohorts:

Cohort 1 - Pediatric Population (n=110):

Children aged 1-17 years undergoing general anesthesia for scheduled surgical procedures. This cohort specifically includes:

  • 55 children with autism spectrum disorder (ASD) diagnosed according to DSM-5 criteria
  • 55 children without ASD (matched controls) This unique population allows investigation of potential neurodevelopmental differences in anesthetic response and EEG patterns in children with ASD.

Cohort 2 - Elderly Adult Population (n=110):

Patients aged >70 years undergoing scheduled surgery under general anesthesia at Bichat-Claude Bernard Hospital. This elderly population is important for studying age-related physiological changes affecting EEG patterns during anesthesia and potential increased sensitivity to anesthetic agents.

Cohort 3 - Procedural Sedation Population (n=110):

Adults (≥18 years) undergoing procedural sedation for diagnostic or therapeutic digestive endoscopy procedures at Louis Mourier Hospital. This cohort provides comparative data on lighter levels of sedation versus general anesthesia.

INCLUSION CRITERIA:

For adult patients:

  • Age ≥18 years (Cohort 2: >70 years; Cohort 3: ≥18 years)
  • Scheduled for general anesthesia (Cohort 2) or procedural sedation (Cohort 3)
  • Pre-anesthetic consultation completed
  • Informed of the study and non-opposition obtained

For pediatric patients (Cohort 1):

  • Age 1-17 years
  • Scheduled for general anesthesia for surgical procedure
  • For ASD subgroup: Confirmed DSM-5 diagnosis of autism spectrum disorder
  • Parental authority holder informed and non-opposition obtained
  • Child informed (if age-appropriate) and non-opposition obtained

EXCLUSION CRITERIA:

For adult patients:

  • Documented cognitive impairment in medical record
  • Patient refusal to participate
  • Patient deprived of liberty or under legal protection
  • Pregnant or breastfeeding women

For pediatric patients:

  • Parental refusal of child's participation
  • Child refusal (if age-appropriate to understand)

DATA COLLECTION:

During routine anesthetic care without any protocol-specific interventions, the following will be recorded:

EEG Monitoring:

  • Continuous multi-channel EEG using BIS (Bispectral Index) monitor
  • Continuous multi-channel EEG using SedLine monitor
  • Processed parameters (BIS index, spectral edge frequency, suppression ratio, etc.)
  • Raw EEG signals recorded in standard EDF format

Synchronized Clinical Annotations:

  • Anesthetic drug administration (agent, dose, route, timing)
  • Clinical events (intubation, surgical incision, emergence, etc.)
  • Hemodynamic parameters (heart rate, blood pressure)
  • Level of consciousness assessments (RASS, clinical signs)
  • Surgical stimulation intensity
  • Adverse events

Patient Characteristics:

  • Demographics (age, sex, weight, height, BMI)
  • Medical history and comorbidities
  • Concomitant medications
  • ASA physical status classification
  • For pediatric cohort: ASD diagnosis and characteristics

All EEG recordings and multi-signal files will be pseudonymized using a unique study identifier before analysis. Data will be stored on secure servers compliant with GDPR regulations.

PRIMARY OBJECTIVE:

To identify features of the electroencephalographic (EEG) signal that significantly correlate with:

  1. Pharmacological parameters: anesthetic drug type, concentration (estimated effect-site concentration), drug combinations, pharmacokinetic/pharmacodynamic properties
  2. Clinical parameters: patient age, comorbidities, surgical stimulation intensity, hemodynamic changes, emergence characteristics

These correlations will be analyzed separately for the induction, maintenance, and emergence phases of general anesthesia and for procedural sedation.

SECONDARY OBJECTIVES:

  1. Develop and validate predictive models using machine learning algorithms to link specific EEG features to anesthetic depth and level of consciousness
  2. Compare EEG spectral and temporal characteristics between pediatric and adult populations during equivalent anesthetic states
  3. Analyze differential effects of commonly used anesthetic agents (propofol, sevoflurane, desflurane, remifentanil) on multi-channel EEG patterns
  4. Investigate specific EEG signatures and anesthetic responses in children with autism spectrum disorder compared to typically developing children
  5. Characterize distinctive EEG patterns during procedural sedation versus general anesthesia
  6. Evaluate inter-individual and intra-individual variability in EEG responses to anesthetic agents
  7. Assess correlation between frontal EEG patterns and clinical signs of anesthetic depth

ENDPOINTS:

Primary Endpoint:

Correlation coefficients (Pearson or Spearman as appropriate) between extracted EEG features (spectral power in different frequency bands, coherence, entropy measures, burst suppression patterns) and pharmacological/clinical variables during different anesthetic phases.

Secondary Endpoints:

  • Performance metrics (sensitivity, specificity, AUC) of predictive models for anesthetic depth
  • Differences in EEG power spectral density between age groups
  • Changes in EEG patterns associated with specific anesthetic agents
  • Differences in EEG characteristics between children with/without ASD
  • Comparison of EEG patterns between sedation and general anesthesia
  • Variance components of inter- and intra-individual EEG variability

STATISTICAL ANALYSIS:

Sample size of 330 participants (110 per cohort) was calculated to provide:

  • Adequate power (>80%) to detect medium effect sizes (r≥0.3) for correlation analyses
  • Sufficient training and validation datasets for machine learning models
  • Subgroup analyses within pediatric cohort (ASD vs non-ASD)

Advanced signal processing techniques will be applied including:

  • Fast Fourier Transform for spectral analysis
  • Wavelet decomposition for time-frequency analysis
  • Entropy measures (spectral entropy, permutation entropy)
  • Coherence and connectivity analyses
  • Machine learning algorithms (random forests, support vector machines, neural networks)

Statistical analyses will use appropriate parametric or non-parametric tests depending on data distribution. Multiple comparison corrections will be applied when appropriate (Bonferroni, FDR). Mixed-effects models will account for repeated measures within individuals.

STUDY DURATION:

  • Recruitment period: 12 months
  • Individual patient participation: Approximately 1 month (interval between pre-anesthetic consultation and surgical procedure/endoscopy)
  • Total study duration: 13 months including data analysis

ETHICAL AND REGULATORY CONSIDERATIONS:

This non-interventional study involves no modifications to standard clinical care, no additional risk to participants, and no experimental interventions. The study has been submitted to the Comité de Protection des Personnes (CPP) for ethical approval and will be registered with the ANSM. Participants (or parents for minors) will receive written information and provide non-opposition for data use. All data management complies with GDPR regulations (MR-003 reference methodology).

EXPECTED OUTCOMES AND IMPACT:

This comprehensive study will provide rich datasets on EEG signal characteristics across diverse anesthetic contexts and patient populations. Results may lead to:

  • Improved algorithms for real-time anesthetic depth monitoring
  • Better understanding of age-related and neurodevelopmental differences in anesthetic response
  • Optimization of anesthetic agent selection and dosing strategies
  • Enhanced safety through more accurate consciousness monitoring
  • New insights into neurophysiological mechanisms of anesthesia
  • Foundation for future development of personalized anesthetic management approaches

The purely observational design ensures maximal safety while generating clinically relevant data to advance the field of neuromonitoring in anesthesia.

Keywords
general anesthesia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07460414
Study groupRoleWhat they receive
COHORT 1 - Pediatric (n=110)Children aged 1-17 years undergoing general anesthesia, including 55 with ASD and 55 without ASD.
COHORT 2 - Elderly Adults (n=110)Patients over 70 years undergoing scheduled surgery under general anesthesia at Bichat-Claude Bernard Hospital.
COHORT 3 - Procedural Sedation (n=110)Adults ≥18 years undergoing procedural sedation for digestive endoscopy at Louis Mourier Hospital.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Correlation of EEG features with pharmacological and clinical parameters during anesthesia

    Identification of electroencephalographic (EEG) signal features (spectral power in delta, theta, alpha, beta, gamma bands; coherence; entropy measures; burst suppression patterns) that demonstrate statistically significant correlation with:

    1. Pharmacological parameters including anesthetic drug type, estimated effect-site concentration, drug combinations, and pharmacokinetic/pharmacodynamic properties
    2. Clinical parameters including patient age, comorbidities, surgical stimulation intensity, hemodynamic changes, and clinical signs of consciousness level

    Correlations will be quantified using Pearson or Spearman correlation coefficients (as appropriate) and analyzed separately for induction, maintenance, and emergence phases. Features will be extracted from multi-channel EEG recordings using advanced signal processing and machine learning techniques.

    Measured: During anesthesia/sedation procedure (typically 1-6 hours per participant)

  2. Development of mathematical tools for EEG analysis during maintenance phase

    Development of new mathematical descriptors to quantify spectral density matrix (SDM) EEG profiles during anesthesia maintenance in adults and children, distinguishing stationary phases from transitions between states. Collaboration with mathematical team at ENS (Prof. David Holcman).

    Measured variables: Novel mathematical descriptors quantifying SDM EEG profiles during anesthetic maintenance. Outcome: Linearity of relationship between quantitative descriptors and clinical anesthesia phase, measured by R² correlation coefficient between new descriptors and clinical classification (awake, induction, light/medium/deep maintenance, emergence).

    Measured: During anesthesia maintenance phase (varies per participant, typically 1-5 hours)

Secondary outcomes (8)
  1. Development of mathematical tools for induction phases

    Development of mathematical analysis tools specific to induction and emergence phases (adults and children). These phases involve much more rapid changes (seconds for induction, tens of seconds for emergence) compared to maintenance (minutes to hours) in both drug doses/concentrations and EEG profiles. Measured variables: New mathematical descriptors specific to induction and emergence phases. Outcome: Linearity of relationship between new descriptors and hypnotic drug doses/concentrations, measured by R² correlation coefficient and slope of dose-descriptor relationship during transition phases.

    Measured: During induction (typically 2-5 minutes) and emergence (typically 5-20 minutes)

  2. Development of mathematical tools for emergence phases

    Development of mathematical analysis tools specific to induction and emergence phases (adults and children). These phases involve much more rapid changes (seconds for induction, tens of seconds for emergence) compared to maintenance (minutes to hours) in both drug doses/concentrations and EEG profiles. Measured variables: New mathematical descriptors specific to induction and emergence phases. Outcome: Linearity of relationship between new descriptors and hypnotic drug doses/concentrations, measured by R² correlation coefficient and slope of dose-descriptor relationship during transition phases.

    Measured: During induction (typically 2-5 minutes) and emergence (typically 5-20 minutes)

  3. Analysis of individual sensitivity to anesthetic drugs during induction

    Test the hypothesis that individual sensitivity to anesthetic drugs can be analyzed in the first minutes of anesthetic induction. Outcome measure: Slope of the linear relationship (established in SO2) between hypnotic dose/concentration and numerical descriptor obtained in SO2. A slope closer to 1 indicates increased sensitivity. Applies to induction protocols used in adults (intravenous propofol injection) and children (sevoflurane inhalation).

    Measured: During induction phase (first 2-5 minutes of anesthetic exposure)

  4. Consistency of individual anesthetic sensitivity across induction

    Test the hypothesis that individual sensitivity to anesthetic drugs identified during induction (SO3) remains constant during maintenance and emergence phases. Outcome: Correlations between slopes of dose/concentration-descriptor relationships (obtained in SO1 and SO2) across the three phases (induction, maintenance, emergence). Assessment of repeatability over time of dose-response relationship, measured by geometric mean error of predicted versus observed transition duration, adjusted for relevant covariates (dose changes, etc.).

    Measured: Throughout entire anesthesia procedure (induction through emergence, typically 1-6 hours)

  5. Consistency of individual anesthetic sensitivity across maintenance

    Test the hypothesis that individual sensitivity to anesthetic drugs identified during induction (SO3) remains constant during maintenance and emergence phases. Outcome: Correlations between slopes of dose/concentration-descriptor relationships (obtained in SO1 and SO2) across the three phases (induction, maintenance, emergence). Assessment of repeatability over time of dose-response relationship, measured by geometric mean error of predicted versus observed transition duration, adjusted for relevant covariates (dose changes, etc.).

    Measured: Throughout entire anesthesia procedure (induction through emergence, typically 1-6 hours)

  6. Consistency of individual anesthetic sensitivity across emergence

    Test the hypothesis that individual sensitivity to anesthetic drugs identified during induction (SO3) remains constant during maintenance and emergence phases. Outcome: Correlations between slopes of dose/concentration-descriptor relationships (obtained in SO1 and SO2) across the three phases (induction, maintenance, emergence). Assessment of repeatability over time of dose-response relationship, measured by geometric mean error of predicted versus observed transition duration, adjusted for relevant covariates (dose changes, etc.).

    Measured: Throughout entire anesthesia procedure (induction through emergence, typically 1-6 hours)

  7. EEG correlates predicting complication-free tracheal extubation in children

    Specific analysis in children of EEG correlates (those already available on SedLine monitor and new tools developed in SO2 for emergence phase) to improve EEG predictive criteria for complication-free tracheal extubation. Measured variable: Occurrence of extubation complications, stratified as:

    (1) No complication, (2) Minor: persistent cough, agitation, transient desaturation (SpO2 >92%), (3) Moderate: laryngospasm resolved by mask ventilation, desaturation <92% requiring intervention, (4) Severe: laryngospasm/bronchospasm requiring reintubation. Outcome: Association between pre-extubation EEG profiles and complication occurrence, analyzed by multinomial logistic regression.

    Measured: During emergence phase preceding tracheal extubation (typically 10-30 minutes)

  8. EEG profile analysis in children with autism spectrum disorder during anesthesia

    Analysis of EEG traces from children with autism spectrum disorder (ASD) using tools described in SO1-SO4. Descriptive analysis as literature lacks data on per-anesthesia EEG profiles in children with ASD pathology. Tests hypothesis of differences in EEG profiles between children with/without ASD. Measured variables: Quantitative EEG descriptors (identified in objectives 1-4) measured in 55 children with ASD and 55 without ASD, adjusted for medication doses and clinical correlates. Outcome: Discrimination capacity between groups, measured by area under ROC curve of classification models (principal component analysis and machine learning methods), with blinded analysis by mathematicians.

    Measured: Throughout entire anesthesia procedure (typically 1-6 hours per participant)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Mar 2026
  2. Study start15 Mar 2026 (estimated)
  3. Primary completion15 Apr 2027 (estimated)
  4. Study completion15 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
330 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07460414
Sponsor's protocol ID
APHP250674
Other IDs
2025-A01891-48
Acronym
SPECTRALADUPED
Status last verified
Mar 2026
First submitted
4 Mar 2026
Last updated
10 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Anesthesia and Sedation, run by Assistance Publique - Hôpitaux de Paris at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 10 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Dan Longrois, MD, PHD (01 47 60 61 35, dan.longrois@aphp.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Correlation of EEG features with pharmacological and clinical parameters during anesthesia (time frame: During anesthesia/sedation procedure (typically 1-6 hours per participant)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in